Fig. 6.
Validation of the signature in an external cohort. a Risk score distribution. b Survival overview. c Patients with a high risk score exhibited poorer overall survival in the validation cohort
Validation of the signature in an external cohort. a Risk score distribution. b Survival overview. c Patients with a high risk score exhibited poorer overall survival in the validation cohort